No Data
Does Transcat (NASDAQ:TRNS) Have A Healthy Balance Sheet?
Northland Securities Maintains Transcat(TRNS.US) With Hold Rating, Maintains Target Price $110
Transcat (TRNS) Receives a Hold From Northland Securities
Craig-Hallum Maintains Buy on Transcat, Raises Price Target to $125
Craig-Hallum Maintains Transcat(TRNS.US) With Buy Rating, Raises Target Price to $125
Oppenheimer Maintains Transcat(TRNS.US) With Buy Rating, Maintains Target Price $130
Independent Director of Transcat Picks Up 30% More StockNo Data
